Timely access to new drugs in a single-payer system: policy analysis from South Korea’s reimbursement framework

Evaluation outcomes, assessment complexity, and budget forecasts are key determinants of reimbursement in Korea. Refinement of HTA processes and adaptive use of RSAs may enhance access efficiency while preserving budgetary sustainability.

Institutions

Dongduk Women's University (KR)

Publication Details

Journal: Expert Review of Pharmacoeconomics & Outcomes Research
Published: 2025-09-16
DOI: https://doi.org/10.1080/14737167.2025.2561020
Primary Topic: Pharmaceutical Economics and Policy
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Timely access to new drugs in a single-payer system: policy analysis from South Korea’s reimbursement framework

Sep 16, 2025

Expert Review of Pharmacoeconomics & Outcomes Research

Pharmaceutical Economics and Policy

article

Timely access to new drugs in a single-payer system: policy analysis from South Korea’s reimbursement framework

September 16, 2025article en

Abstract

Expert Review of Pharmacoeconomics & Outcomes Research

Dongduk Women's University (KR)

Openalex Percentile: Top 67%

Pharmaceutical Economics and Policy

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Timely access to new drugs in a single-payer system: policy analysis from South Korea’s reimbursement framework · Expert Review of Pharmacoeconomics & Outcomes Research (2025) | TGRS Research Map | TGRS